Skip to main content
Site Search
Close Search

RNeasy Mini Kit

High-quality total RNA in minutes.

Investigator 24plex QS Kit

Multiplex amplification for human ID, with CODIS and European standard markers.

QIAsphere

Monitor and manage your QIAsphere-ready instruments from anywhere, using any mobile device.

Smart ideas, deep insights

Get inspiring content today – with a free face mask.

QIAGEN Clinical Insight (QCI) Interpret

Transparent, evidence-based NGS interpretation and reporting.

Find out more

QIAGENbioinformatics.com

COVID-19 testing and research

Up to date protocols and list of COVID-19 testing and research solutions.

RNeasy Mini Kit

High-quality total RNA in minutes.

Smart ideas, deep insights

Get inspiring content today – with a free face mask.

QuantiFERON-TB Gold Plus

Detect TB infection with confidence.

QIAGEN Clinical Insight (QCI) Interpret

Transparent, evidence-based NGS interpretation and reporting.

Digital PCR

Digital is the new absolute

Who we are

Learn about who we are and what we do to make improvements in life possible.

Join the QIAGEN team

Latest information on COVID-19

News, testing solutions and stories covering global efforts in the fight against COVID-19.

Our stories

Explore our digital magazine full of customer stories and videos on scientific breakthroughs and healthcare advances.

    Market Strategy

    Read our equity story, financial disclosures and how we create shareholder value.

      Latest News

      Read up on our latest press releases or peruse our various media archives.

      Contact Us

      Thank you for choosing QIAGEN. If you have questions about QIAGEN, our products or your order, this page should help you find the answers and contacts you need.

      Overview

      QIAGEN Spotlight Session - QuantiFERON

      Home  >  Investor Relations  >  Events & Presentations  >  QIAGEN Spotlight Session - QuantiFERON

      QIAGEN Spotlight Session – QuantiFERON

      The first QIAGEN Spotlight Session focused on QuantiFERON, our modern blood-based test for latent tuberculosis. The session provided insights into our strategic priorities and highlighted the latest developments across the business, including the announcement of Inpeco as our new end-to-end automation partner.

      Downloads

        Presentation     Transcript  

      Watch the QuantiFERON Spotlight on-demand

      Full event replay
      Opening remarks
      Business perspectives
      Inpeco automation workflow
      Interview with Inpeco CEO Riccardo Triunfo
      Q&A

      Speaker bios

      Download all